| Trial ID: | L5334 |
| Source ID: | NCT02305199
|
| Associated Drug: |
Hartmann's Solution
|
| Title: |
Hartmann's Solution and Normal Saline in Type II Diabetes Patients
|
| Acronym: |
|
| Status: |
WITHDRAWN
|
| Study Results: |
NO
|
| Results: |
|
| Conditions: |
Diabetes Mellitus, Type 2
|
| Interventions: |
DRUG: Hartmann's solution|DRUG: Normal saline
|
| Outcome Measures: |
Primary: Postoperative glucose level, Being the first blood sampling done a day before the surgery as the baseline, postoperative blood glucose levels checked at one hour after the surgery, and first and second postoperative days, up to postoperative day 2 | Secondary: Postoperative Stress hormone level, Insulin, Glucagon, Free Fatty Acid, Cortisol, Lactate, Ketone body are checked at one hour after the surgery, and first and second postoperative days, up to postoperative day 2
|
| Sponsor/Collaborators: |
Sponsor: Yeungnam University College of Medicine
|
| Gender: |
ALL
|
| Age: |
ADULT, OLDER_ADULT
|
| Phases: |
|
| Enrollment: |
0
|
| Study Type: |
INTERVENTIONAL
|
| Study Designs: |
Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: TRIPLE (PARTICIPANT, INVESTIGATOR, OUTCOMES_ASSESSOR)|Primary Purpose: PREVENTION
|
| Start Date: |
2015-01-01
|
| Completion Date: |
2017-04-01
|
| Results First Posted: |
|
| Last Update Posted: |
2017-04-20
|
| Locations: |
Yeungnam University Hospital, Daegu, 705-717, Korea, Republic of
|
| URL: |
https://clinicaltrials.gov/show/NCT02305199
|
